Recent work reported from this laboratory (1 to 7) has shown that clostridia grow and produce toxins readily in anoxic muscle in zivo, and that they are readily introduced into dog muscles during the course of traumatizing procedures. Moreover, our previous experiments have suggested that these and perhaps other bacteria may be responsible for a toxic factor contributing to shock in traumatizing wounds. Since clostridia are known to be frequent contaminants of war wounds (8, 9) it appeared desirable to study the physiologic action of clostridial toxins in order to determine whether these toxins could produce shock 4 alone or in synergy with blood or plasma loss following trauma.
Recent work reported from this laboratory (1 to 7) has shown that clostridia grow and produce toxins readily in anoxic muscle in zivo, and that they are readily introduced into dog muscles during the course of traumatizing procedures. Moreover, our previous experiments have suggested that these and perhaps other bacteria may be responsible for a toxic factor contributing to shock in traumatizing wounds. Since clostridia are known to be frequent contaminants of war wounds (8, 9) it appeared desirable to study the physiologic action of clostridial toxins in order to determine whether these toxins could produce shock 4 alone or in synergy with blood or plasma loss following trauma.
Since the action of these toxins depends on the amount used, the route of injection, and the rate of injection, we have given attention to these variables. Wright (12) has criticized studies on the pharmacologic effects of Cl. welchii toxins in which large doses of toxin were administered rapidly, in a manner unlikely to have a parallel in the' clinical disease. Study of the effects of the Cl. welchii toxic filtrate has a particular interest in that the specific enzymatic nature of its probable principal component (the alpha toxin or lecithinase) (13) 1 This is publication No. 630 of the Cancer Commission of Harvard University, and No. VIII of the series entitled "The Toxic Factors in Experimental Traumatic Shock." 2 The work described in this paper was done under a contract, recommended by the Committee on Medical Research, between the Office of Scientific Research and Development and the Massachusetts General Hospital. 8 Grateful acknowledgment is due the Josiah Macy, Jr. Foundation for a grant for the histopathological studies.
4We regard shock as a syndrome in which there is primarily a decline in the effective circulating blood volume, followed by a decrease in the minute volume output of the heart, an increase in peripheral vascular resistance, an eventual fall in mean arterial blood pressure and a progressive increase in tissue anoxia, resulting in death. This definition agrees with conceptions commonly held (10, 11) . and one of its minor components (hyaluronidase) (14) are known. The lethal properties of Cl. welchii (Type A) organisms appear to correlate well with their ability to produce the alpha toxin (15) . It is therefore possible to interpret physiologic and pathologic effects of these toxins on the basis of their substrate specificities. MATERIAL Logan (16) to contain chiefly alpha toxin, a small amount of theta toxin (accounting for fewer than 5 out of a 1,000 MLD), and 100 to 200 viscosity reducing units and 2,000 to 6,000 mucin clot prevention units of hyaluronidase activity per ml. The Cl. welchii hyaluronidase preparation contained no demonstrable alpha toxin, 120 van Heyningen units of theta toxin, and greater than 6,400 mucin clot prevention units of hyaluronidase activity per ml. (16) . Another enzyme, a decarboxylase, which converts histidine to histamine, frequently present in strains of Cl. welchii (17), was not found in the toxic filtrates used in these experiments.
In the majority of experiments, mongrel dogs weighing between 8 and 15 kgm. were fasted overnight, anesthetized intravenously with 30 mgm. of sodium pentobarbital per kgm. of body weight, and were maintained as indicated under light anesthesia by subsequent small doses of the anesthetic. The trachea was exposed and cannulated so that the oxygen consumption could be recorded by a spirometer; the right carotid artery was cannulated and attached to a recording mercury manometer; and the left external jugular vein was exposed so that a catheter could be inserted to the level of the right auricle, in order to obtain mixed venous blood samples and to measure 5 The first and third have been generously supplied by Cl. welchii toxic filtrate, which was stored in 30 per cent glycerol, was diluted 1: 3 with physiologic saline solution before intramuscular injection, and a control experiment was done by using 10 per cent glycerol in saline. Intravenous administration was either "rapid" (the dose being given within 5 minutes) or "slow" (further diluted with saline and given by intravenous drip over a period of 2 to 3 hours). The level of free alpha toxin in the blood stream was followed by means of a modification of the egg yolk turbidimetric method of van Heyningen (20) .
In tabulating results, dosages have been expressed in terms of mouse MLD per kgm. body weight. For comparison between the species, it will be recalled that the lethal dose for a mouse should be in the vicinity of 40 to 50 MLD per kgm.
The control dogs, listed in Table I , were treated in precisely the same way as the experimental animals, with the exception that toxic filtrate was omitted. A number of other controls were run, in which either Cl. welchii immunized dogs were used, or in which Cl. welchis antitoxin was mixed with the toxic filtrate prior to injection into the animal. Trhe experiments on the effect of toxic filtrates on immunized animals will be discussed at length in a future communication (22 Hg within 5 to 10 minutes, and then maintained this level for an hour or more before the terminal decline. When smaller amounts of toxic filtrate were given, or when it was given more slowly, there was no immediate response of the blood pressure, but the pressure declined more gradually. Table I summarizes a number of changes occurring in animals in this group. It will be observed that the cardiac output, blood pressure, hemoglobin, and hematocrit show significant declines prior to death of the animal. There was, however, no significant change in the peripheral vascular resistance. A decrease in the whole blood hemoglobin and hematocrit levels provided the earliest consistent reflection of the downward trend of the animal. Figure 1 illustrates the interrelationships of these data in a typical animal. In 2 cases, the level of free alpha toxin in the blood stream was followed by van Heyningen's method (20) , while toxin was administered by slow intravenous drip. The rise in the level of free alpha toxin in the blood stream was paralleled by a rise in the plasma hemoglobin and a fall in the hematocrit. In 10 out of the 12 dogs receiving a lethal dose of toxin (in which plasma hemoglobin was quantitated), the plasma was deep red, and the plasma hemoglobin reached levels between 1 and 7 grams per cent. Plasma protein concentration 7 in amounts sufficient to maintain normal plasma volume and hematocrit values. Eight control (uninjected) dogs were maintained under similar experimental conditions. Six of these controls were also given albumin to prevent the hemoconcentration which usually occurs in dogs anesthetized with sodium pentobarbital under these conditions. The remaining 2 were untreated.
2. Two intramuscularly injected dogs were allowed to go 5 to 6 hours without treatment; at the end of this period sufficient albumin was given to replace lost plasma and blood. Before the albumin was given, tourniquets were placed around both thighs to prevent further local plasma loss.
3. In 2 dogs, casts (Castex) were placed around both legs extending from the foot pads to the groin. The toxic filtrate was injected through the casts into the triceps surae muscles. Since extensive swelling occurred above the casts (in the regions of the abdominal and gluteal muscles where the amount of swelling could not be quantitated), one was given constant albumin injection, as in (1) and the other was given a terminal albumin injection, as in (2) .
The results of these experiments indicated that the decrease in cardiac output which occurred following administration of Cl. welchii toxic filtrate intramuscularly could largely be explained by the local loss of plasma into the muscle and subcutaneous tissue in the vicinity of the injection site. Replacement of this plasma loss restored the normal cardiac output temporarily, but did not prevent further plasma loss into the damaged area. In fact, the fluid loss appeared to be somewhat increased by administration of plasma albumin, although the cardiovascular state was better maintained (cf . Table III beyond their confines, occurring in the gluteal, perineal, and retroperitoneal regions if casts were placed about both lower extremities, and toxin was injected through the casts into the underlying musculature. In this case, in a small area immediately adjacent to the injection site, there were muscle necrosis and hemorrhage, but the casted portion of the extremity was edema free. Three dogs injected subcutaneously with Cl. welchii toxic filtrate presented a picture of local edema without detectable generalized effects, similar to the situation seen with the intramuscular injection.
Cl. welchii hyaluronidase, -intramuscular route Five-tenths ml. of hyaluronidase was injected into each. triceps surae muscle group of an anesthetized dog. During the following 6 hours there was no evidence of generalized effects of the toxin on the cardiac output, peripheral resistance, pulse, respiration, or temperature. There was an area of edema and extravasation of blood 6 cm. in diameter in the region of the injection sites, but no generalized edema of the extremities. Postmortem examination was otherwise completely negative.
Pathologic findings 8 Cl. welchii toxic filtrate given intravenously in lethal dosage to non-immunized dogs: lungs and liver showed marked congestion and edema. The weights of the lungs were significantly greater than those of control dogs (21) . The small intestine, spleen, and kidneys revealed similar findings to a lesser degree. Twenty to 50 ml. of hemolyzed fluid was found in the pleural and peritoneal cavities. Where a similar dosage of toxic filtrate was given to dogs previously immunized there was no congestion of lungs, liver, or other organs. An interesting finding in such animals, however, was the presence of considerable numbers of polymorphonuclear leucocytes in the walls of the pulmonary and adrenal capillaries.
Cl. welchii toxic filtrate given intramuscularly in lethal dosage to non-immunized dogs: there occurred necrosis and liquefaction of the injected muscle in the vicinity of the injection site, with ex-.
tensive edema of the surrounding muscle and fascia, and a lesser degree of edema of neighboring muscles. The duodenum showed a marked capillary engorgement. The lungs, liver, adrenal, and spleen were negative. Marked cloudy swelling of the kidney was seen in one animal in this group (No. 240 ). An excellent, detailed description of the effects of the filtrate on muscle has been given by Robb-Smith (23) .
Pathologic findings associated with intravenous injection of Cl. welchii toxins have been reported previously (24 to 27). There appears to be some variation among the animal species (dogs, mice, rabbits, guinea pigs) used by the various investigators, in the sensitivity of the erythrocytes to hemolysis and in the localization of the sites of major hemorrhagic manifestations. DISCUSSION An attempt has been made to vary the dose, the rate, and the route of administration of Cl. welchii toxic filtrate in order.to gain a better understanding of its action on the animal. It is impossible to say what quantity of toxic filtrate might be elaborated in gas gangrene or clostridial myositis. It is therefore difficult to transfer information provided by the present experiments to the human problem. It is probable, however, that the closest simulation of clinical conditions is achieved where a relatively small dose of toxic filtrate is administered intramuscularly. Such injections have been demonstrated to evoke vascular fluid loss of considerable proportions. The additive effect of this fluid loss may be sufficient to convert into shock a traumatic condition which would not ordinarily produce this syndrome. Furthermore, the local damage to capillaries resulting from the toxins is long-lasting. If primary shock is averted by adequate therapy, clostridial toxins may introduce the possibility of delayed or secondary shock as a result of continuing fluid loss from damaged capillaries.
The action of the toxic filtrate, administered either intravenously or intramuscularly, is consistent with the damaging effect its lecithinase component might theoretically be expected to have on cell surfaces. In the case of the erythrocyte, the result is rupture of the cell wall; in the case of the vascular endothelium, the result is leakage of whole blood or plasma through a damaged membrane.
It is worth calling attention to the point that either purified Cl. welchii alpha toxin or purified Cl. welchii hyaluronidase in the absence of the other produced little edema during a 6-hour interval when injected intramuscularly. The edemaforming power of a filtrate containing these 2 toxins (plus a small amount of theta toxin and possibly other unknown toxins) was, however, very great during this time interval. This observation is of interest in connection with the finding of McClean (28) that Cl. welchii is able to use hyaluronic acid as a metabolite.
A number of other effects of Cl. welchii toxins (Type A) have been described and are discussed in recent reviews on the subject (29, 12 (32) that once the Cl. welchii lecithinase is in contact with its substrate, lecithin, it becomes difficult for antitoxin, when added to the reaction mixture, to prevent the enzymatic process from continuing. It appears that the lecithin and antitoxin compete with each other for the lecithinase. This finding offers a partial explanation for the lack of effectiveness of antitoxin when the disease is well established (i.e. when a large amount of lecithinase is in contact with its substrate). (3) It has been found possible to protect mice and dogs from a lethal intravenous dose of Cl. welchii filtrate by means of lecithin or total lipids if these are given either in advance of or shortly after the filtrate (33) . It is probable that the lecithin protects the animal (by a substrate partition effect) only from the lecithinase component of the filtrate. One may conclude that the lecithinase is in this instance the principal toxic component of the filtrate.
On the other hand, purified alpha toxin produced little edema on intramuscular injection into our dogs. This evidence suggests that collagenase (31) , unknown toxins, or a synergistic effect of the combination of toxins plays important roles in the production of edema when a toxic filtrate is given intramuscularly.
An interesting teleological point is raised by the experiments of DeKruif and Bollman (34) , who found that the capacity of Cl. welchii to invade the animal body was largely dependent on its power to produce toxin. Washed Cl. welchii bacilli or spores were infective only in very large numbers; if non-lethal quantities of toxin were added to organisms, only 1/10,000 of the quantity of washed spores or bacilli was necessary to kill the animal. The alpha toxin or lecithinase appears to serve the Cl. welchii organism by destroying the surface of animal cells, making the interior available for the nutrition of the Cl. welchii organism.
The possibility that effects ascribed to the toxins might be due to substances used in the bacterial culture media has been ruled out by the prevention of these toxic effects both by active immunization of animals and by administration of antitoxin in advance of the toxin (22) .
SUMMARY
A number of characteristics of the syndrome of traumatic shock may be produced by Cl. welchii (Type A) toxic filtrate given by either intramuscular or intravenous route. Intravenous injection results in intravascular hemolysis, decline in cardiac output and blood pressure, increase in prothrombin time, edema and hemorrhage into the lungs and small intestine, and congestion of the liver, spleen, and kidneys. Intramuscular or subcutaneous injection is followed by massive edema spreading from the injection site and by severe hemoconcentration. The effects of the toxic filtrate given by this route are chiefly local, and the lack of hemolysis is evidence of the inability of the alpha toxin to reach the general circulation in appreciable concentration.
Purified Cl. welchii alpha toxin injected intramuscularly produced little edema. Purified Cl. welchii hyaluronidase similarly had little effect on intramuscular injection. The edema-forming property of the unpurified Cl. welchni toxic filtrate thus appears to be due to the presence of other toxins or to a synergistic effect of a combination of toxins.
Cl. welchii toxins may play an important role in certain cases of traumatic shock by aggravating fluid loss into the injured region.
